Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2296)	2/24/2000 12:51:00 AM
From: out_of_the_loop	Respond to of 5582

Gents, I personally believe (my opinion only) that they are advertising commensurate with their present production capacity and free publicity. In other words, they are ramping and waiting for real articles to come out and for international distribution channels to be finalized and filled. Hank has said that he does not believe that any high caliber journal will ever print any Zicam study. I do not agree but that is my personal opinion based on seeing zinc losenge studies in prominent journals and seeing other "nontraditional" articles appear in journals - such as the use of antibiotics for peptic ulcer disease caused by a bacterium - once considered ridiculous, now considered to be the likely cause. In any case, we are indeed entitled to form our own opinions based on our own judgement, confidence & experience - and then act (or trade) accordingly. In general, I think management has used good judgement. I do not think the AJIC "debacle" was all that big of a deal in the long run. I do think they should have made it clear when they released the info on Dr. Hirt's study that it was not the studies mentioned in the previous press releases because I think some people who did get that impression sold off and were intimidated into selling by people trying to promote a "negative" image of a company not interested in mainstream research.